Physalis alkekengi var. franchetii Extracts Exert Antitumor Effects on Non-Small Cell Lung Cancer and Multiple Myeloma by Inhibiting STAT3 Signaling

References

• Guo Y, Liu H, Ding L, Oppong M, Pan G, Qiu F. LC-MS/MS method for simultaneous determination of flavonoids and physalins in rat plasma: application to pharmacokinetic study after oral administration of Physalis alkekengi var. franchetii (Chinese lantern) extract. Biomed Chromatography. 2017;31(10):e3970. doi:10.1002/bmc.3970
   Web of Science ®Google Scholar
• Zhang L, Ding AW. On the subsequent revision of pharmacopoeia of the People’s Republic of China: volume Ⅰ (2010 Edition)——Based on the Regulation of Crude Drugs Standard in the Japanese Pharmacopoeia(16th Edition). J Nanjing Univ Trad Chinese Med. 2012;28(4):301–365.
   Google Scholar
• Wang ZY, Su -T-T, Li N. Study on extraction and antimicrobial activity of extracts from physalis alkekengil l. var. francheti(mast.) makino. Food Sci Technol. 2009.
   Google Scholar
• Zhu F, Dai C, Fu Y, et al. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling. Oncotarget. 2016;7(8):9462–9476. doi:10.18632/oncotarget.7051
   PubMedGoogle Scholar
• Kang H, Kwon SR, Choi HY. Inhibitory effect of Physalis alkekengi L Var Franchetii Extract and Its Chloroform Fraction on LPS or LPS/IFN-?-Stimulated inflammatory response in peritoneal macrophages. J Ethnopharmacol. 2011;135(1):95–101.
   PubMed Web of Science ®Google Scholar
• Magalhães HIF, Torres MR, Costa-Lotufo LV, et al. In-vitro and in-vivo antitumour activity of physalins B and D from Physalis angulata. J Pharm Pharmacol. 2006;58(2):235–241. doi:10.1211/jpp.58.2.0011
   PubMed Web of Science ®Google Scholar
• Soares MB, Bellintani MC, Ribeiro IM, Tomassini TC, Ribeiro DSR. inhibition of macrophage activation and lipopolysaccaride-induced death by seco-steroids purified from Physalis Angulata L. Eur J Pharmacol. 2003;459(1):107.
   PubMed Web of Science ®Google Scholar
• Castro DP, Figueiredo MB, Ribeiro IM, Tomassini TC, Azambuja P, Garcia ES. Immune depression in Rhodnius prolixus by seco-steroids, physalins. J Insect Physiol. 2008;54(3):555–562. doi:10.1016/j.jinsphys.2007.12.004
   PubMed Web of Science ®Google Scholar
• Zheng Y, Chen Y, Ren Y, Luan L, Wu Y. Quantitative and transformation product analysis of major active physalins from Physalis alkekengi var. franchetii (Chinese lantern) using ultraperformance liquid chromatography with electrospray ionisation tandem mass spectrometry and time-of-flight mass spectrometry. Phytochem Anal. 2012;23(4):337–344. doi:10.1002/pca.1363
   PubMed Web of Science ®Google Scholar
• Hsu CC, Wu YC, Farh L, et al. Physalin B from Physalis angulata triggers the NOXA-related apoptosis pathway of human melanoma A375 cells. Food Chem Toxicol. 2012;50(3–4):619–624. doi:10.1016/j.fct.2011.12.017
   PubMed Web of Science ®Google Scholar
• Wu SY, Leu YL, Chang YL, et al. Physalin F induces cell apoptosis in human renal carcinoma cells by targeting NF-kappaB and generating reactive oxygen species. PLoS One. 2012;7(7):e40727. doi:10.1371/journal.pone.0040727
   PubMed Web of Science ®Google Scholar
• Helvaci S, Kokdil G, Kawai M, Duran N, Duran G, Guvenc A. Antimicrobial activity of the extracts and physalin D from Physalis alkekengi and evaluation of antioxidant potential of physalin D. Pharm Biol. 2010;48(2):142–150. doi:10.3109/13880200903062606
   PubMed Web of Science ®Google Scholar
• Ji L, Yuan Y, Luo L, et al. Physalins with anti-inflammatory activity are present in Physalis alkekengi var. franchetii and can function as Michael reaction acceptors. Steroids. 2012;77(5):441–447. doi:10.1016/j.steroids.2011.11.016
   PubMed Web of Science ®Google Scholar
• Zhang D, Ma X, Sun W, Cui P, Lu Z. Down-regulated FSTL5 promotes cell proliferation and survival by affecting Wnt/β-catenin signaling in hepatocellular carcinoma. Int J Clin Exp Pathol. 2015;8(3):3386–3394.
   PubMed Web of Science ®Google Scholar
• Naito S, von Eschenbach AC, Giavazzi R, Fidler IJ. Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Res. 1986;46(8):4109–4115.
   PubMed Web of Science ®Google Scholar
• Koo MY, Park J, Lim JM, et al. Selective inhibition of the function of tyrosine-phosphorylated STAT3 with a phosphorylation site-specific intrabody. Proc Natl Acad Sci U S A. 2014;111(17):6269–6274. doi:10.1073/pnas.1316815111
   PubMed Web of Science ®Google Scholar
• Rubió L, Motilva MJ, Romero MP. Recent advances in biologically active compounds in herbs and spices: a review of the most effective antioxidant and anti-inflammatory active principles. Crit Rev Food Sci Nutr. 2013;53(9):943–953. doi:10.1080/10408398.2011.574802
   PubMed Web of Science ®Google Scholar
• Gullett NP, Ruhul Amin AR, Bayraktar S, et al. Cancer Prevention with Natural Compounds. 2010:258–281.
   Google Scholar
• He H, Zang LH, Feng YS, et al. Physalin A induces apoptotic cell death and protective autophagy in HT1080 human fibrosarcoma cells. J Nat Prod. 2013;76(5):880–888. doi:10.1021/np400017k
   PubMed Web of Science ®Google Scholar
• Shin JM, Lee KM, Lee HJ, Yun JH, Nho CW. Physalin A regulates the Nrf2 pathway through ERK and p38 for induction of detoxifying enzymes. BMC Complement Altern Med. 2019;19(1):101. doi:10.1186/s12906-019-2511-y
   PubMedGoogle Scholar
• He H, Zang LH, Feng YS, et al. Physalin A induces apoptosis via p53-Noxa-mediated ROS generation, and autophagy plays a protective role against apoptosis through p38-NF-kappaB survival pathway in A375-S2 cells. J Ethnopharmacol. 2013;148(2):544–555. doi:10.1016/j.jep.2013.04.051
   PubMed Web of Science ®Google Scholar
• Chiang HC, Jaw SM, Chen CF, Kan WS. Antitumor agent, physalin F from Physalis angulata L. Anticancer Res. 1992;12(3):837–843.
   PubMed Web of Science ®Google Scholar
• Nagafuji S, Okabe H, Akahane H, Abe F. Trypanocidal constituents in plants 4. Withanolides from the Aerial Parts of Physalis Angulata. Biol Pharm Bull. 2004;27(2):193–197.
   PubMed Web of Science ®Google Scholar
• Wu SJ, Ng LT, Lin DL, Huang SN, Wang SS, Lin CC. Physalis peruviana extract induces apoptosis in human Hep G2 cells through CD95/CD95L system and the mitochondrial signaling transduction pathway. Cancer Lett. 2004;215(2):199–208. doi:10.1016/j.canlet.2004.05.001
   PubMed Web of Science ®Google Scholar
• Wu SJ, Ng LT, Chen CH, Lin DL, Wang SS, Lin CC. Antihepatoma activity of Physalis angulata and P. peruviana extracts and their effects on apoptosis in human Hep G2 cells. Life Sci. 2004;74(16):2061–2073. doi:10.1016/j.lfs.2003.09.058
   PubMed Web of Science ®Google Scholar
• Lee CC, Houghton P. Cytotoxicity of plants from Malaysia and Thailand used traditionally to treat cancer. J Ethnopharmacol. 2005;100(3):237–243. doi:10.1016/j.jep.2005.01.064
   PubMed Web of Science ®Google Scholar
• Choi JY, Lee SJ, Lee SJ, et al. Analysis and tentative structure elucidation of new anthocyanins in fruit peel of Vitis coignetiae Pulliat (meoru) using LC-MS/MS: contribution to the overall antioxidant activity. J Sep Sci. 2010;33(9):1192–1197. doi:10.1002/jssc.200900748
   PubMed Web of Science ®Google Scholar
• Darnell JE Jr. STATs and gene regulation. Science. 1997;277(5332):1630–1635. doi:10.1126/science.277.5332.1630
   PubMed Web of Science ®Google Scholar
• Bromberg J, Darnell JE. The role of STATs in transcriptional control and their impact on cellular function. Oncogene. 2000;19(21):2468–2473. doi:10.1038/sj.onc.1203476
   PubMed Web of Science ®Google Scholar
• Liu J, Xu X, Feng X, Zhang B, Wang J. Adenovirus-mediated delivery of bFGF small interfering RNA reduces STAT3 phosphorylation and induces the depolarization of mitochondria and apoptosis in glioma cells U251. J Exp Clin Cancer Res. 2011;30(1):80. doi:10.1186/1756-9966-30-80
   PubMedGoogle Scholar
• Klemm JD, Schreiber SL, Crabtree GR. Dimerization as a regulatory mechanism in signal transduction. Annu Rev Immunol. 1998;16:569–592. doi:10.1146/annurev.immunol.16.1.569
   PubMed Web of Science ®Google Scholar
• Rane SG, Reddy EP. Janus kinases: components of multiple signaling pathways. Oncogene. 2000;19(49):5662–5679. doi:10.1038/sj.onc.1203925
   PubMed Web of Science ®Google Scholar
• Banerjee K, Resat H. Constitutive activation of STAT3 in breast cancer cells: A review. Int J Cancer. 2016;138(11):2570–2578. doi:10.1002/ijc.29923
   PubMed Web of Science ®Google Scholar
• Alvarez JV, Greulich H, Sellers WR, Meyerson M, Frank DA. Signal transducer and activator of transcription 3 is required for the oncogenic effects of non–small-cell lung cancer–associated mutations of the epidermal growth factor receptor. Cancer Res. 2006;66(6):3162–3168. doi:10.1158/0008-5472.CAN-05-3757
   PubMed Web of Science ®Google Scholar
• Yin W, Cheepala S, Roberts JN, Sysonchan K, Digiovanni J, Clifford JL. Active Stat3 is required for survival of human squamous cell carcinoma cells in serum-free conditions. Mol Cancer. 2006;5(1):15. doi:10.1186/1476-4598-5-15
   PubMedGoogle Scholar
• Kusaba T, Nakayama T, Yamazumi K, et al. Activation of STAT3 is a marker of poor prognosis in human colorectal cancer. Oncol Rep. 2006;15(6):1445–1451.
   PubMed Web of Science ®Google Scholar
• Morikawa T, Baba Y, Mai Y, et al. STAT3 expression, molecular features, inflammation patterns and prognosis in a database of 724 colorectal cancers. Clin Cancer Res off J Am Assoc Cancer Res. 2011;17(6):1452–1462. doi:10.1158/1078-0432.CCR-10-2694
   PubMed Web of Science ®Google Scholar
• Jove R. STAT proteins: novel molecular targets for cancer drug discovery. Expert Opin Ther Targets. 2004;8(5):409–422. doi:10.1517/14728222.8.5.409
   PubMed Web of Science ®Google Scholar
• Wang X, Crowe PJ, Goldstein D, Yang JL. STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers (review). Int J Oncol. 2012;41(4):1181–1191. doi:10.3892/ijo.2012.1568
   PubMed Web of Science ®Google Scholar
• CatlettFalcone R, Dalton WS, Jove R. STAT proteins as novel targets for cancer therapy. Curr Opin Oncol. 1999;11(6):490–496. doi:10.1097/00001622-199911000-00010
   PubMedGoogle Scholar
• Gouilleux-Gruart V, Gouilleux F, Desaint C, et al. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood. 1996;87(5):1692–1697. doi:10.1182/blood.V87.5.1692.1692
   PubMed Web of Science ®Google Scholar
• WeberNordt RM, Egen C, Wehinger J, et al. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood. 1996;88(3):809–816. doi:10.1182/blood.V88.3.809.809
   PubMed Web of Science ®Google Scholar
• Harada D, Takigawa N, Kiura K. The role of STAT3 in non-small cell lung cancer. Cancers. 2014;6(2):708–722. doi:10.3390/cancers6020708
   PubMed Web of Science ®Google Scholar
• Catlett-Falcone R, Landowski TH, Oshiro MM, et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity. 1999;10(1):105–115. doi:10.1016/S1074-7613(00)80011-4
   PubMed Web of Science ®Google Scholar
• Hirano T, Nakajima K, Hibi M. Signaling mechanisms through gp130: a model of the cytokine system. Cytokine Growth Factor Rev. 1997;8(4):241–252. doi:10.1016/S1359-6101(98)80005-1
   PubMedGoogle Scholar
• Tkach M, Rosemblit C, Rivas MA, et al. p42/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth. Endocr Relat Cancer. 2013;20(2):197–212. doi:10.1530/ERC-12-0194
   PubMed Web of Science ®Google Scholar
• Aziz MH, Hafeez BB, Sand JM, et al. Protein kinase Cvarepsilon mediates Stat3Ser727 phosphorylation, Stat3-regulated gene expression, and cell invasion in various human cancer cell lines through integration with MAPK cascade (RAF-1, MEK1/2, and ERK1/2). Oncogene. 2010;29(21):3100–3109. doi:10.1038/onc.2010.63
   PubMed Web of Science ®Google Scholar
• Lin H, Chen MC, Chiu CY, Song YM, Lin SY. Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells. J Biol Chem. 2007;282(5):2776–2784. doi:10.1074/jbc.M607234200
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim JE, Liu HY, Cao W, Chen J. Regulation of interleukin-6-induced hepatic insulin resistance by mammalian target of rapamycin through the STAT3-SOCS3 pathway. J Biol Chem. 2008;283(2):708–715. doi:10.1074/jbc.M708568200
   PubMed Web of Science ®Google Scholar
• Wakahara R, Kunimoto H, Tanino K, et al. Phospho-Ser727 of STAT3 regulates STAT3 activity by enhancing dephosphorylation of phospho-Tyr705 largely through TC45. Genes Cells. 2012;17(2):132–145. doi:10.1111/j.1365-2443.2011.01575.x
   PubMed Web of Science ®Google Scholar
• Shi X, Zhang H, Paddon H, Lee G, Cao X, Pelech S. Phosphorylation of STAT3 serine-727 by cyclin-dependent kinase 1 is critical for nocodazole-induced mitotic arrest. Biochemistry. 2006;45(18):5857–5867. doi:10.1021/bi052490j
   PubMed Web of Science ®Google Scholar
• Butturini E, Cavalieri E, de Prati AC, et al. Two naturally occurring terpenes, dehydrocostuslactone and costunolide, decrease intracellular GSH content and inhibit STAT3 activation. PLoS One. 2011;6(5):e20174. doi:10.1371/journal.pone.0020174
   PubMed Web of Science ®Google Scholar
• Ashkenazi A, Fairbrother WJ, Leverson JD, Souers AJ. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors. Nat Rev Drug Discov. 2017;16(4):273–284. doi:10.1038/nrd.2016.253
   PubMed Web of Science ®Google Scholar
• Schimmer AD, Welsh K, Pinilla C, et al. Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity. Cancer Cell. 2004;5(1):25–35. doi:10.1016/S1535-6108(03)00332-5
   PubMed Web of Science ®Google Scholar
• Boulares AH, Yakovlev AG, Ivanova V, et al. Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-Resistant PARP mutant increases rates of apoptosis in transfected cells. J Biol Chem. 1999;274(33):22932–22940.
   PubMed Web of Science ®Google Scholar